BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Merck & Co., Inc. (MRK) Investing $15 Million in Facility to Take on More Vaccines


5/3/2012 7:41:03 AM

Triangle Business Journal by Jason deBruyn, Staff Writer

Pharmaceutical giant Merck & Co. Inc. announced a $15 million investment in two projects at its Wilson facility on Wednesday.

In one project, Merck (NYSE: MRK) will renovate manufacturing space and in another project it will build a new cold storage facility for vaccine packaging to support the company’s growing vaccines business. Both projects are scheduled to finish in the next year.

Currently, the majority of products packaged in Wilson are stored at room temperature. Vaccines are refrigerated or frozen and require cold storage and expansive storage space.

Merck’s Wilson site employs roughly 400 people. The facility improvements will not directly add new jobs this year; however, the construction process managed by Jacobs Engineering may bring temporary construction job opportunities to the site, says Merck.

Merck’s Wilson campus covers 225 acres and the Packaging and Stability Testing facility serves as a packaging center for many of the company’s pharmaceutical products for the U.S. and Canadian markets. It opened in June 1983 and began operating in August of that year. Based in New Jersey, Merck also operates a vaccine manufacturing facility in Durham.

For the first quarter of 2012, Merck reported $11.7 billion in sales and $1.7 billion in net income; both figures were increases from the same quarter in 2011.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES